Oleanolic acid alleviated pressure overload-induced cardiac remodeling

Area of Science:

• Cardiovascular Research
• Pharmacology
• Molecular Biology

Background:

• Oleanolic acid (OA) exhibits anti-inflammatory and antioxidant properties.
• Previous studies showed OA's benefits in diabetic cardiomyopathy and autoimmune myocarditis.
• The effect of OA on pressure overload-induced cardiac remodeling is largely unknown.

Purpose of the Study:

• To investigate the effects of OA on cardiac remodeling induced by pressure overload.
• To elucidate the underlying molecular mechanisms of OA's action.
• To assess OA's therapeutic potential in cardiac remodeling.

Main Methods:

• Mice underwent aortic banding (AB) surgery and were treated with OA.
• Echocardiography and hemodynamic measurements assessed cardiac function.
• Histological analysis and RT-PCR evaluated cardiac hypertrophy and fibrosis.
• In vitro studies examined OA's effects on Angiotensin II-stimulated cells.

Main Results:

• OA treatment ameliorated systolic and diastolic dysfunction post-AB.
• OA decreased mRNA expression of cardiac hypertrophy and fibrosis markers.
• Pressure overload-induced phosphorylation of Akt, mTOR, and related proteins was attenuated by OA.
• OA inhibited Angiotensin II-induced cardiomyocyte hypertrophy and fibrosis in vitro.

Conclusions:

• Oleanolic acid suppresses pressure overload-induced cardiac hypertrophy.
• OA acts partly by inhibiting the Akt/mTOR pathway.
• OA may offer therapeutic benefits for long-term pressure overload-induced cardiac remodeling.